Adverse changes in key chronic kidney disease care outcome metrics since the onset of the COVID-19 pandemic: experience from an established provincial renal program.

Bevilacqua, Micheli; Induruwage, Dilshani; Williams, Janet; Djurdjev, Ognjenka; Levin, Adeera

Bevilacqua, Micheli; Induruwage, Dilshani; Williams, Janet; Djurdjev, Ognjenka; Levin, Adeera.

Bevilacqua M; Division of Nephrology, University of British Columbia, Vancouver, British Columbia, Canada; British Columbia Renal Agency, Vancouver, British Columbia, Canada. Electronic address: Mike.bevilacqua@bcrenal.ca.
Induruwage D; British Columbia Renal Agency, Vancouver, British Columbia, Canada.
Williams J; British Columbia Renal Agency, Vancouver, British Columbia, Canada.
Djurdjev O; British Columbia Renal Agency, Vancouver, British Columbia, Canada.
Levin A; Division of Nephrology, University of British Columbia, Vancouver, British Columbia, Canada; British Columbia Renal Agency, Vancouver, British Columbia, Canada.

Kidney Int ; 101(5): 1081-1082, 2022 05.

Article in English | MEDLINE | ID: covidwho-1708651

Subject(s)

COVID-19; Renal Insufficiency, Chronic; Benchmarking; Female; Humans; Male; Pandemics; Renal Insufficiency, Chronic/epidemiology; Renal Insufficiency, Chronic/therapy; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Renal Insufficiency, Chronic / COVID-19 Type of study: Observational study / Prognostic study Limits: Female / Humans / Male Language: English Journal: Kidney Int Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google